Tuning tumor-specific T-cell activation: a matter of costimulation?
Abken
Hinrich
H
Tumorgenetik, Klinik I für Innere Medizin, Universität zu Köln, D-50931 Köln, Germany. hinrich.abken@medizin.uni-koeln.de
Hombach
Andreas
A
Heuser
Claudia
C
Kronfeld
Kai
K
Seliger
Barbara
B
D000069594:Abatacept; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000276:immunology; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000276:immunology; D018122:B7-1 Antigen / Q000276:immunology; D018106:CD28 Antigens / Q000276:immunology; D060908:CTLA-4 Antigen; D006801:Humans; D018796:Immunoconjugates; D016219:Immunotherapy, Adoptive / Q000379:methods; D008213:Lymphocyte Activation / Q000276:immunology*; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology*
D015703:Antigens, CD; D000943:Antigens, Differentiation; D015295:Antigens, Tumor-Associated, Carbohydrate; D018122:B7-1 Antigen; D018106:CD28 Antigens; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D018796:Immunoconjugates; D000069594:Abatacept